Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
293,500
-5,500 (-1.84%)
At close: Jun 5, 2025, 3:30 PM KST

Hanmi Pharm. Statistics

Total Valuation

Hanmi Pharm. has a market cap or net worth of KRW 3.72 trillion. The enterprise value is 4.13 trillion.

Market Cap 3.72T
Enterprise Value 4.13T

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date Jul 29, 2025
Ex-Dividend Date Jun 27, 2025

Share Statistics

Hanmi Pharm. has 12.68 million shares outstanding. The number of shares has decreased by -0.07% in one year.

Current Share Class 12.68M
Shares Outstanding 12.68M
Shares Change (YoY) -0.07%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 7.81%
Owned by Institutions (%) 22.18%
Float 6.20M

Valuation Ratios

The trailing PE ratio is 34.17 and the forward PE ratio is 23.04. Hanmi Pharm.'s PEG ratio is 1.57.

PE Ratio 34.17
Forward PE 23.04
PS Ratio 2.51
PB Ratio 2.93
P/TBV Ratio 3.49
P/FCF Ratio 33.48
P/OCF Ratio 25.65
PEG Ratio 1.57
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.12, with an EV/FCF ratio of 37.15.

EV / Earnings 37.92
EV / Sales 2.79
EV / EBITDA 14.12
EV / EBIT 21.20
EV / FCF 37.15

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.37.

Current Ratio 1.16
Quick Ratio 0.67
Debt / Equity 0.37
Debt / EBITDA 1.62
Debt / FCF 4.25
Interest Coverage 8.50

Financial Efficiency

Return on equity (ROE) is 10.01% and return on invested capital (ROIC) is 7.01%.

Return on Equity (ROE) 10.01%
Return on Assets (ROA) 6.16%
Return on Invested Capital (ROIC) 7.01%
Return on Capital Employed (ROCE) 14.32%
Revenue Per Employee 636.38M
Profits Per Employee 46.75M
Employee Count 2,330
Asset Turnover 0.75
Inventory Turnover 2.39

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1.03% in the last 52 weeks. The beta is 0.69, so Hanmi Pharm.'s price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change +1.03%
50-Day Moving Average 259,710.00
200-Day Moving Average 279,472.50
Relative Strength Index (RSI) 56.82
Average Volume (20 Days) 88,911

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Hanmi Pharm. had revenue of KRW 1.48 trillion and earned 108.92 billion in profits. Earnings per share was 8,589.65.

Revenue 1.48T
Gross Profit 804.14B
Operating Income 194.89B
Pretax Income 149.46B
Net Income 108.92B
EBITDA 292.49B
EBIT 194.89B
Earnings Per Share (EPS) 8,589.65
Full Income Statement

Balance Sheet

The company has 218.53 billion in cash and 472.39 billion in debt, giving a net cash position of -253.86 billion or -20,020.02 per share.

Cash & Cash Equivalents 218.53B
Total Debt 472.39B
Net Cash -253.86B
Net Cash Per Share -20,020.02
Equity (Book Value) 1.27T
Book Value Per Share 87,879.22
Working Capital 97.54B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 145.11 billion and capital expenditures -33.94 billion, giving a free cash flow of 111.17 billion.

Operating Cash Flow 145.11B
Capital Expenditures -33.94B
Free Cash Flow 111.17B
FCF Per Share 8,767.49
Full Cash Flow Statement

Margins

Gross margin is 54.23%, with operating and profit margins of 13.14% and 7.35%.

Gross Margin 54.23%
Operating Margin 13.14%
Pretax Margin 10.08%
Profit Margin 7.35%
EBITDA Margin 19.73%
EBIT Margin 13.14%
FCF Margin 7.50%

Dividends & Yields

This stock pays an annual dividend of 1,250.00, which amounts to a dividend yield of 0.43%.

Dividend Per Share 1,250.00
Dividend Yield 0.43%
Dividend Growth (YoY) 66.67%
Years of Dividend Growth 7
Payout Ratio 26.67%
Buyback Yield 0.07%
Shareholder Yield 0.49%
Earnings Yield 2.93%
FCF Yield 2.99%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date Dec 27, 2023
Split Type Forward
Split Ratio 1.02

Scores

Hanmi Pharm. has an Altman Z-Score of 4.72.

Altman Z-Score 4.72
Piotroski F-Score n/a